IKT R&D Expenses
Inhibikase Therapeutics Inc · R&D Expenses
IKT R&D Expenses
Latest reported$38.24Mperiod ending
IKT R&D Expenses ($846.39K → $38.24M)
Annual R&D Expenses
High-resolution chart · PNG
IKT r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 29,793,146 | |
| 17,210,548 | |
| 13,618,348 | |
| 12,034,985 | |
| 11,359,104 | |
| 893,802 | |
| 2,552,711 | |
| 3,647,108 | |
| 1,755,692 | |
| 846,386 |